NYSE - Delayed Quote USD

Quest Diagnostics Incorporated (DGX)

Compare
151.79
-2.24
(-1.45%)
At close: January 10 at 4:00:02 PM EST
152.00
+0.21
+(0.14%)
After hours: January 10 at 6:16:02 PM EST

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. James E. Davis Chairman, CEO & President 2.88M -- 1963
Mr. Sam A. Samad Executive VP & CFO 1.33M -- 1970
Mr. Michael E. Prevoznik J.D. Senior VP & General Counsel 881.23k -- 1962
Ms. Catherine T. Doherty Executive Vice President of Regional Businesses 1M -- 1963
Mr. Karthik Kuppusamy Ph.D. Senior Vice President of Clinical Solutions 840.3k -- 1970
Mr. Michael J. Deppe Senior VP, Corporate Controller & Chief Accounting Officer -- -- 1967
Mr. Murali Balakumar Senior VP, Chief Information & Digital Officer -- -- --
Mr. Shawn C. Bevec Vice President of Investor Relations -- -- --
Ms. Kristin Lee Wallace Esq. Senior VP & Chief Compliance Officer -- -- --
Mr. Garry Clark Senior VP and Chief Marketing & Communications Officer -- -- --

Quest Diagnostics Incorporated

500 Plaza Drive
Secaucus, NJ 07094
United States
973 520 2700 https://www.questdiagnostics.com
Sector: 
Healthcare
Full Time Employees: 
50,000

Description

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Corporate Governance

Quest Diagnostics Incorporated’s ISS Governance QualityScore as of January 1, 2025 is 5. The pillar scores are Audit: 9; Board: 8; Shareholder Rights: 1; Compensation: 5.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

January 14, 2025 at 12:00 AM UTC

Ex-Dividend Date

January 29, 2025 at 12:00 AM UTC

Dividend Date

January 30, 2025 at 1:30 PM UTC

Quest Diagnostics Incorporated Earnings Date

Recent Events

December 4, 2024 at 8:00 PM UTC

at Evercore ISI HealthCONx Conference

October 23, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

October 22, 2024 at 12:30 PM UTC

Q3 2024 Earnings Call

October 22, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 29, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 19, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 24, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

July 23, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 3, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 21, 2024 at 12:00 AM UTC

11-K: Annual report of employee stock purchase

Related Tickers